- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Dalradian Resources Inc. (TSX:DNA) has closed its bought deal prospectus offering. Dalradian issued 19,205,000 units at a price of $0.90 per Unit for gross proceeds of $17,284,500.
Dalradian Resources Inc. (TSX:DNA) has closed its bought deal prospectus offering. Dalradian issued 19,205,000 units at a price of $0.90 per Unit for gross proceeds of $17,284,500, and also completed a concurrent non-brokered private placement for gross proceeds of $10,080,000.
As quoted in the press release:
The net proceeds from the Offering and the Concurrent Placement are expected to be used by the Company for exploration and development activities at the Company’s Curraghinalt gold project and for general working capital purposes.
Click here to read the Dalradian Resources Inc. (TSX:DNA) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â